🎉 M&A multiples are live!
Check it out!

CareDx Valuation Multiples

Discover revenue and EBITDA valuation multiples for CareDx and similar public comparables like Genus, 4basebio, and ToolGen.

CareDx Overview

About CareDx

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company’s commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.


Founded

1998

HQ

United States of America
Employees

650

Website

caredx.com

Financials

LTM Revenue $344M

LTM EBITDA $28.8M

EV

$815M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

CareDx Financials

CareDx has a last 12-month revenue of $344M and a last 12-month EBITDA of $28.8M.

In the most recent fiscal year, CareDx achieved revenue of $334M and an EBITDA of -$34.0M.

CareDx expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See CareDx valuation multiples based on analyst estimates

CareDx P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $280M $334M XXX XXX XXX
Gross Profit $210M $178M XXX XXX XXX
Gross Margin 75% 53% XXX XXX XXX
EBITDA -$84.9M -$34.0M XXX XXX XXX
EBITDA Margin -30% -10% XXX XXX XXX
Net Profit -$76.6M -$190M XXX XXX XXX
Net Margin -27% -57% XXX XXX XXX
Net Debt n/a n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

CareDx Stock Performance

As of April 15, 2025, CareDx's stock price is $19.

CareDx has current market cap of $1.0B, and EV of $815M.

See CareDx trading valuation data

CareDx Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$815M $1.0B XXX XXX XXX XXX $0.53

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

CareDx Valuation Multiples

As of April 15, 2025, CareDx has market cap of $1.0B and EV of $815M.

CareDx's trades at 2.4x LTM EV/Revenue multiple, and 28.3x LTM EBITDA.

Analysts estimate CareDx's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for CareDx and 10K+ public comps

CareDx Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $815M XXX XXX XXX
EV/Revenue 2.4x XXX XXX XXX
EV/EBITDA -24.0x XXX XXX XXX
P/E 19.9x XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF 25.8x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get CareDx Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

CareDx Valuation Multiples

CareDx's NTM/LTM revenue growth is 12%

CareDx's revenue per employee for the last fiscal year averaged $0.5M, while opex per employee averaged $0.4M for the same period.

Over next 12 months, CareDx's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate CareDx's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for CareDx and other 10K+ public comps

CareDx Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 19% XXX XXX XXX XXX
EBITDA Margin -10% XXX XXX XXX XXX
EBITDA Growth -60% XXX XXX XXX XXX
Rule of 40 (SaaS-only) 2% XXX XXX XXX XXX
Revenue per Employee $0.5M XXX XXX XXX XXX
Opex per Employee $0.4M XXX XXX XXX XXX
S&M Expenses to Revenue 24% XXX XXX XXX XXX
G&A Expenses to Revenue 37% XXX XXX XXX XXX
R&D Expenses to Revenue 22% XXX XXX XXX XXX
Opex to Revenue 83% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

CareDx Public Comps

See public comps and valuation multiples for Genomics & Personalized Medicine and Health Data & Analytics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
EZZ Life Science XXX XXX XXX XXX XXX XXX
Epigenomics XXX XXX XXX XXX XXX XXX
ToolGen XXX XXX XXX XXX XXX XXX
4basebio XXX XXX XXX XXX XXX XXX
Genus XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

CareDx M&A and Investment Activity

CareDx acquired  XXX companies to date.

Last acquisition by CareDx was  XXXXXXXX, XXXXX XXXXX XXXXXX . CareDx acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by CareDx

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About CareDx

When was CareDx founded? CareDx was founded in 1998.
Where is CareDx headquartered? CareDx is headquartered in United States of America.
How many employees does CareDx have? As of today, CareDx has 650 employees.
Who is the CEO of CareDx? CareDx's CEO is Mr. John Walter Hanna, Jr.
Is CareDx publicy listed? Yes, CareDx is a public company listed on NAS.
What is the stock symbol of CareDx? CareDx trades under CDNA ticker.
When did CareDx go public? CareDx went public in 2014.
Who are competitors of CareDx? Similar companies to CareDx include e.g. EZZ Life Science, Epigenomics, ToolGen, 4basebio.
What is the current market cap of CareDx? CareDx's current market cap is $1.0B
What is the current revenue of CareDx? CareDx's last 12-month revenue is $344M.
What is the current EBITDA of CareDx? CareDx's last 12-month EBITDA is $28.8M.
What is the current EV/Revenue multiple of CareDx? Current revenue multiple of CareDx is 2.4x.
What is the current EV/EBITDA multiple of CareDx? Current EBITDA multiple of CareDx is 28.3x.
What is the current revenue growth of CareDx? CareDx revenue growth between 2023 and 2024 was 19%.
Is CareDx profitable? Yes, CareDx is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.